Global High-end Generic Drug Supply, Demand and Key Producers, 2023-2029
The global High-end Generic Drug market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
As people's demand for medical care increases, pharmaceutical technology advances and the prevalence of chronic diseases increases, and pharmaceutical R&D activities and investments increase, the high-end generic drug industry is developing well. However, the industry also faces various challenges, such as strict market supervision, high research and development costs, expiration of drug patents, and declining revenue. Companies need to continue to innovate and adapt to these challenges to remain competitive in the market. In addition, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for high-end generic pharmaceutical companies to be nimble in responding to emerging public health needs.
Generic drugs refer to similar drugs developed based on existing original drugs and are usually cheaper than the original drugs. The emergence of high-end generic drugs can effectively reduce patients' medical costs and promote the development of the pharmaceutical industry.
This report studies the global High-end Generic Drug demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for High-end Generic Drug, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of High-end Generic Drug that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global High-end Generic Drug total market, 2018-2029, (USD Million)
Global High-end Generic Drug total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: High-end Generic Drug total market, key domestic companies and share, (USD Million)
Global High-end Generic Drug revenue by player and market share 2018-2023, (USD Million)
Global High-end Generic Drug total market by Type, CAGR, 2018-2029, (USD Million)
Global High-end Generic Drug total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global High-end Generic Drug market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Viatris, Teva, Organon, Sun Pharma, Bausch Health, Mylan NV, Novartis AG, Pfizer Inc and Fresenius SE & Co, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World High-end Generic Drug market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global High-end Generic Drug Market, By Region:
1. How big is the global High-end Generic Drug market?
2. What is the demand of the global High-end Generic Drug market?
3. What is the year over year growth of the global High-end Generic Drug market?
4. What is the total value of the global High-end Generic Drug market?
5. Who are the major players in the global High-end Generic Drug market?
As people's demand for medical care increases, pharmaceutical technology advances and the prevalence of chronic diseases increases, and pharmaceutical R&D activities and investments increase, the high-end generic drug industry is developing well. However, the industry also faces various challenges, such as strict market supervision, high research and development costs, expiration of drug patents, and declining revenue. Companies need to continue to innovate and adapt to these challenges to remain competitive in the market. In addition, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for high-end generic pharmaceutical companies to be nimble in responding to emerging public health needs.
Generic drugs refer to similar drugs developed based on existing original drugs and are usually cheaper than the original drugs. The emergence of high-end generic drugs can effectively reduce patients' medical costs and promote the development of the pharmaceutical industry.
This report studies the global High-end Generic Drug demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for High-end Generic Drug, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of High-end Generic Drug that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global High-end Generic Drug total market, 2018-2029, (USD Million)
Global High-end Generic Drug total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: High-end Generic Drug total market, key domestic companies and share, (USD Million)
Global High-end Generic Drug revenue by player and market share 2018-2023, (USD Million)
Global High-end Generic Drug total market by Type, CAGR, 2018-2029, (USD Million)
Global High-end Generic Drug total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global High-end Generic Drug market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Viatris, Teva, Organon, Sun Pharma, Bausch Health, Mylan NV, Novartis AG, Pfizer Inc and Fresenius SE & Co, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World High-end Generic Drug market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global High-end Generic Drug Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Prescription Drugs
- Non-prescription Drugs
- Hospital
- Pharmacy
- Others
- Viatris
- Teva
- Organon
- Sun Pharma
- Bausch Health
- Mylan NV
- Novartis AG
- Pfizer Inc
- Fresenius SE & Co
- Lupin Limited
- Endo Pharmaceuticals Inc
- Aurobindo Pharma Limited
- Warner (India) Pharma Private Limited
- Shijiazhuang Pharma Group
- Fosun Pharma
- Yangtze River Pharmaceutical Group
- Sichuan KELUN PHARMACEUTICAL Co., Ltd.
- Nantong Beite Pharmaceutical Machinery Co.,Ltd
- CR Pharmaceutical Group
1. How big is the global High-end Generic Drug market?
2. What is the demand of the global High-end Generic Drug market?
3. What is the year over year growth of the global High-end Generic Drug market?
4. What is the total value of the global High-end Generic Drug market?
5. Who are the major players in the global High-end Generic Drug market?
1 SUPPLY SUMMARY
1.1 High-end Generic Drug Introduction
1.2 World High-end Generic Drug Market Size & Forecast (2018 & 2022 & 2029)
1.3 World High-end Generic Drug Total Market by Region (by Headquarter Location)
1.3.1 World High-end Generic Drug Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States High-end Generic Drug Market Size (2018-2029)
1.3.3 China High-end Generic Drug Market Size (2018-2029)
1.3.4 Europe High-end Generic Drug Market Size (2018-2029)
1.3.5 Japan High-end Generic Drug Market Size (2018-2029)
1.3.6 South Korea High-end Generic Drug Market Size (2018-2029)
1.3.7 ASEAN High-end Generic Drug Market Size (2018-2029)
1.3.8 India High-end Generic Drug Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 High-end Generic Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 High-end Generic Drug Major Market Trends
2 DEMAND SUMMARY
2.1 World High-end Generic Drug Consumption Value (2018-2029)
2.2 World High-end Generic Drug Consumption Value by Region
2.2.1 World High-end Generic Drug Consumption Value by Region (2018-2023)
2.2.2 World High-end Generic Drug Consumption Value Forecast by Region (2024-2029)
2.3 United States High-end Generic Drug Consumption Value (2018-2029)
2.4 China High-end Generic Drug Consumption Value (2018-2029)
2.5 Europe High-end Generic Drug Consumption Value (2018-2029)
2.6 Japan High-end Generic Drug Consumption Value (2018-2029)
2.7 South Korea High-end Generic Drug Consumption Value (2018-2029)
2.8 ASEAN High-end Generic Drug Consumption Value (2018-2029)
2.9 India High-end Generic Drug Consumption Value (2018-2029)
3 WORLD HIGH-END GENERIC DRUG COMPANIES COMPETITIVE ANALYSIS
3.1 World High-end Generic Drug Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global High-end Generic Drug Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for High-end Generic Drug in 2022
3.2.3 Global Concentration Ratios (CR8) for High-end Generic Drug in 2022
3.3 High-end Generic Drug Company Evaluation Quadrant
3.4 High-end Generic Drug Market: Overall Company Footprint Analysis
3.4.1 High-end Generic Drug Market: Region Footprint
3.4.2 High-end Generic Drug Market: Company Product Type Footprint
3.4.3 High-end Generic Drug Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: High-end Generic Drug Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: High-end Generic Drug Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: High-end Generic Drug Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: High-end Generic Drug Consumption Value Comparison
4.2.1 United States VS China: High-end Generic Drug Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: High-end Generic Drug Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based High-end Generic Drug Companies and Market Share, 2018-2023
4.3.1 United States Based High-end Generic Drug Companies, Headquarters (States, Country)
4.3.2 United States Based Companies High-end Generic Drug Revenue, (2018-2023)
4.4 China Based Companies High-end Generic Drug Revenue and Market Share, 2018-2023
4.4.1 China Based High-end Generic Drug Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies High-end Generic Drug Revenue, (2018-2023)
4.5 Rest of World Based High-end Generic Drug Companies and Market Share, 2018-2023
4.5.1 Rest of World Based High-end Generic Drug Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies High-end Generic Drug Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World High-end Generic Drug Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Prescription Drugs
5.2.2 Non-prescription Drugs
5.3 Market Segment by Type
5.3.1 World High-end Generic Drug Market Size by Type (2018-2023)
5.3.2 World High-end Generic Drug Market Size by Type (2024-2029)
5.3.3 World High-end Generic Drug Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World High-end Generic Drug Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Pharmacy
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World High-end Generic Drug Market Size by Application (2018-2023)
6.3.2 World High-end Generic Drug Market Size by Application (2024-2029)
6.3.3 World High-end Generic Drug Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Viatris
7.1.1 Viatris Details
7.1.2 Viatris Major Business
7.1.3 Viatris High-end Generic Drug Product and Services
7.1.4 Viatris High-end Generic Drug Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Viatris Recent Developments/Updates
7.1.6 Viatris Competitive Strengths & Weaknesses
7.2 Teva
7.2.1 Teva Details
7.2.2 Teva Major Business
7.2.3 Teva High-end Generic Drug Product and Services
7.2.4 Teva High-end Generic Drug Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Teva Recent Developments/Updates
7.2.6 Teva Competitive Strengths & Weaknesses
7.3 Organon
7.3.1 Organon Details
7.3.2 Organon Major Business
7.3.3 Organon High-end Generic Drug Product and Services
7.3.4 Organon High-end Generic Drug Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Organon Recent Developments/Updates
7.3.6 Organon Competitive Strengths & Weaknesses
7.4 Sun Pharma
7.4.1 Sun Pharma Details
7.4.2 Sun Pharma Major Business
7.4.3 Sun Pharma High-end Generic Drug Product and Services
7.4.4 Sun Pharma High-end Generic Drug Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Sun Pharma Recent Developments/Updates
7.4.6 Sun Pharma Competitive Strengths & Weaknesses
7.5 Bausch Health
7.5.1 Bausch Health Details
7.5.2 Bausch Health Major Business
7.5.3 Bausch Health High-end Generic Drug Product and Services
7.5.4 Bausch Health High-end Generic Drug Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Bausch Health Recent Developments/Updates
7.5.6 Bausch Health Competitive Strengths & Weaknesses
7.6 Mylan NV
7.6.1 Mylan NV Details
7.6.2 Mylan NV Major Business
7.6.3 Mylan NV High-end Generic Drug Product and Services
7.6.4 Mylan NV High-end Generic Drug Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Mylan NV Recent Developments/Updates
7.6.6 Mylan NV Competitive Strengths & Weaknesses
7.7 Novartis AG
7.7.1 Novartis AG Details
7.7.2 Novartis AG Major Business
7.7.3 Novartis AG High-end Generic Drug Product and Services
7.7.4 Novartis AG High-end Generic Drug Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Novartis AG Recent Developments/Updates
7.7.6 Novartis AG Competitive Strengths & Weaknesses
7.8 Pfizer Inc
7.8.1 Pfizer Inc Details
7.8.2 Pfizer Inc Major Business
7.8.3 Pfizer Inc High-end Generic Drug Product and Services
7.8.4 Pfizer Inc High-end Generic Drug Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Pfizer Inc Recent Developments/Updates
7.8.6 Pfizer Inc Competitive Strengths & Weaknesses
7.9 Fresenius SE & Co
7.9.1 Fresenius SE & Co Details
7.9.2 Fresenius SE & Co Major Business
7.9.3 Fresenius SE & Co High-end Generic Drug Product and Services
7.9.4 Fresenius SE & Co High-end Generic Drug Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Fresenius SE & Co Recent Developments/Updates
7.9.6 Fresenius SE & Co Competitive Strengths & Weaknesses
7.10 Lupin Limited
7.10.1 Lupin Limited Details
7.10.2 Lupin Limited Major Business
7.10.3 Lupin Limited High-end Generic Drug Product and Services
7.10.4 Lupin Limited High-end Generic Drug Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Lupin Limited Recent Developments/Updates
7.10.6 Lupin Limited Competitive Strengths & Weaknesses
7.11 Endo Pharmaceuticals Inc
7.11.1 Endo Pharmaceuticals Inc Details
7.11.2 Endo Pharmaceuticals Inc Major Business
7.11.3 Endo Pharmaceuticals Inc High-end Generic Drug Product and Services
7.11.4 Endo Pharmaceuticals Inc High-end Generic Drug Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Endo Pharmaceuticals Inc Recent Developments/Updates
7.11.6 Endo Pharmaceuticals Inc Competitive Strengths & Weaknesses
7.12 Aurobindo Pharma Limited
7.12.1 Aurobindo Pharma Limited Details
7.12.2 Aurobindo Pharma Limited Major Business
7.12.3 Aurobindo Pharma Limited High-end Generic Drug Product and Services
7.12.4 Aurobindo Pharma Limited High-end Generic Drug Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Aurobindo Pharma Limited Recent Developments/Updates
7.12.6 Aurobindo Pharma Limited Competitive Strengths & Weaknesses
7.13 Warner (India) Pharma Private Limited
7.13.1 Warner (India) Pharma Private Limited Details
7.13.2 Warner (India) Pharma Private Limited Major Business
7.13.3 Warner (India) Pharma Private Limited High-end Generic Drug Product and Services
7.13.4 Warner (India) Pharma Private Limited High-end Generic Drug Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Warner (India) Pharma Private Limited Recent Developments/Updates
7.13.6 Warner (India) Pharma Private Limited Competitive Strengths & Weaknesses
7.14 Shijiazhuang Pharma Group
7.14.1 Shijiazhuang Pharma Group Details
7.14.2 Shijiazhuang Pharma Group Major Business
7.14.3 Shijiazhuang Pharma Group High-end Generic Drug Product and Services
7.14.4 Shijiazhuang Pharma Group High-end Generic Drug Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Shijiazhuang Pharma Group Recent Developments/Updates
7.14.6 Shijiazhuang Pharma Group Competitive Strengths & Weaknesses
7.15 Fosun Pharma
7.15.1 Fosun Pharma Details
7.15.2 Fosun Pharma Major Business
7.15.3 Fosun Pharma High-end Generic Drug Product and Services
7.15.4 Fosun Pharma High-end Generic Drug Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Fosun Pharma Recent Developments/Updates
7.15.6 Fosun Pharma Competitive Strengths & Weaknesses
7.16 Yangtze River Pharmaceutical Group
7.16.1 Yangtze River Pharmaceutical Group Details
7.16.2 Yangtze River Pharmaceutical Group Major Business
7.16.3 Yangtze River Pharmaceutical Group High-end Generic Drug Product and Services
7.16.4 Yangtze River Pharmaceutical Group High-end Generic Drug Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Yangtze River Pharmaceutical Group Recent Developments/Updates
7.16.6 Yangtze River Pharmaceutical Group Competitive Strengths & Weaknesses
7.17 Sichuan KELUN PHARMACEUTICAL Co., Ltd.
7.17.1 Sichuan KELUN PHARMACEUTICAL Co., Ltd. Details
7.17.2 Sichuan KELUN PHARMACEUTICAL Co., Ltd. Major Business
7.17.3 Sichuan KELUN PHARMACEUTICAL Co., Ltd. High-end Generic Drug Product and Services
7.17.4 Sichuan KELUN PHARMACEUTICAL Co., Ltd. High-end Generic Drug Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 Sichuan KELUN PHARMACEUTICAL Co., Ltd. Recent Developments/Updates
7.17.6 Sichuan KELUN PHARMACEUTICAL Co., Ltd. Competitive Strengths & Weaknesses
7.18 Nantong Beite Pharmaceutical Machinery Co.,Ltd
7.18.1 Nantong Beite Pharmaceutical Machinery Co.,Ltd Details
7.18.2 Nantong Beite Pharmaceutical Machinery Co.,Ltd Major Business
7.18.3 Nantong Beite Pharmaceutical Machinery Co.,Ltd High-end Generic Drug Product and Services
7.18.4 Nantong Beite Pharmaceutical Machinery Co.,Ltd High-end Generic Drug Revenue, Gross Margin and Market Share (2018-2023)
7.18.5 Nantong Beite Pharmaceutical Machinery Co.,Ltd Recent Developments/Updates
7.18.6 Nantong Beite Pharmaceutical Machinery Co.,Ltd Competitive Strengths & Weaknesses
7.19 CR Pharmaceutical Group
7.19.1 CR Pharmaceutical Group Details
7.19.2 CR Pharmaceutical Group Major Business
7.19.3 CR Pharmaceutical Group High-end Generic Drug Product and Services
7.19.4 CR Pharmaceutical Group High-end Generic Drug Revenue, Gross Margin and Market Share (2018-2023)
7.19.5 CR Pharmaceutical Group Recent Developments/Updates
7.19.6 CR Pharmaceutical Group Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 High-end Generic Drug Industry Chain
8.2 High-end Generic Drug Upstream Analysis
8.3 High-end Generic Drug Midstream Analysis
8.4 High-end Generic Drug Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 High-end Generic Drug Introduction
1.2 World High-end Generic Drug Market Size & Forecast (2018 & 2022 & 2029)
1.3 World High-end Generic Drug Total Market by Region (by Headquarter Location)
1.3.1 World High-end Generic Drug Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States High-end Generic Drug Market Size (2018-2029)
1.3.3 China High-end Generic Drug Market Size (2018-2029)
1.3.4 Europe High-end Generic Drug Market Size (2018-2029)
1.3.5 Japan High-end Generic Drug Market Size (2018-2029)
1.3.6 South Korea High-end Generic Drug Market Size (2018-2029)
1.3.7 ASEAN High-end Generic Drug Market Size (2018-2029)
1.3.8 India High-end Generic Drug Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 High-end Generic Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 High-end Generic Drug Major Market Trends
2 DEMAND SUMMARY
2.1 World High-end Generic Drug Consumption Value (2018-2029)
2.2 World High-end Generic Drug Consumption Value by Region
2.2.1 World High-end Generic Drug Consumption Value by Region (2018-2023)
2.2.2 World High-end Generic Drug Consumption Value Forecast by Region (2024-2029)
2.3 United States High-end Generic Drug Consumption Value (2018-2029)
2.4 China High-end Generic Drug Consumption Value (2018-2029)
2.5 Europe High-end Generic Drug Consumption Value (2018-2029)
2.6 Japan High-end Generic Drug Consumption Value (2018-2029)
2.7 South Korea High-end Generic Drug Consumption Value (2018-2029)
2.8 ASEAN High-end Generic Drug Consumption Value (2018-2029)
2.9 India High-end Generic Drug Consumption Value (2018-2029)
3 WORLD HIGH-END GENERIC DRUG COMPANIES COMPETITIVE ANALYSIS
3.1 World High-end Generic Drug Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global High-end Generic Drug Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for High-end Generic Drug in 2022
3.2.3 Global Concentration Ratios (CR8) for High-end Generic Drug in 2022
3.3 High-end Generic Drug Company Evaluation Quadrant
3.4 High-end Generic Drug Market: Overall Company Footprint Analysis
3.4.1 High-end Generic Drug Market: Region Footprint
3.4.2 High-end Generic Drug Market: Company Product Type Footprint
3.4.3 High-end Generic Drug Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: High-end Generic Drug Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: High-end Generic Drug Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: High-end Generic Drug Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: High-end Generic Drug Consumption Value Comparison
4.2.1 United States VS China: High-end Generic Drug Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: High-end Generic Drug Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based High-end Generic Drug Companies and Market Share, 2018-2023
4.3.1 United States Based High-end Generic Drug Companies, Headquarters (States, Country)
4.3.2 United States Based Companies High-end Generic Drug Revenue, (2018-2023)
4.4 China Based Companies High-end Generic Drug Revenue and Market Share, 2018-2023
4.4.1 China Based High-end Generic Drug Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies High-end Generic Drug Revenue, (2018-2023)
4.5 Rest of World Based High-end Generic Drug Companies and Market Share, 2018-2023
4.5.1 Rest of World Based High-end Generic Drug Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies High-end Generic Drug Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World High-end Generic Drug Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Prescription Drugs
5.2.2 Non-prescription Drugs
5.3 Market Segment by Type
5.3.1 World High-end Generic Drug Market Size by Type (2018-2023)
5.3.2 World High-end Generic Drug Market Size by Type (2024-2029)
5.3.3 World High-end Generic Drug Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World High-end Generic Drug Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Pharmacy
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World High-end Generic Drug Market Size by Application (2018-2023)
6.3.2 World High-end Generic Drug Market Size by Application (2024-2029)
6.3.3 World High-end Generic Drug Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Viatris
7.1.1 Viatris Details
7.1.2 Viatris Major Business
7.1.3 Viatris High-end Generic Drug Product and Services
7.1.4 Viatris High-end Generic Drug Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Viatris Recent Developments/Updates
7.1.6 Viatris Competitive Strengths & Weaknesses
7.2 Teva
7.2.1 Teva Details
7.2.2 Teva Major Business
7.2.3 Teva High-end Generic Drug Product and Services
7.2.4 Teva High-end Generic Drug Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Teva Recent Developments/Updates
7.2.6 Teva Competitive Strengths & Weaknesses
7.3 Organon
7.3.1 Organon Details
7.3.2 Organon Major Business
7.3.3 Organon High-end Generic Drug Product and Services
7.3.4 Organon High-end Generic Drug Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Organon Recent Developments/Updates
7.3.6 Organon Competitive Strengths & Weaknesses
7.4 Sun Pharma
7.4.1 Sun Pharma Details
7.4.2 Sun Pharma Major Business
7.4.3 Sun Pharma High-end Generic Drug Product and Services
7.4.4 Sun Pharma High-end Generic Drug Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Sun Pharma Recent Developments/Updates
7.4.6 Sun Pharma Competitive Strengths & Weaknesses
7.5 Bausch Health
7.5.1 Bausch Health Details
7.5.2 Bausch Health Major Business
7.5.3 Bausch Health High-end Generic Drug Product and Services
7.5.4 Bausch Health High-end Generic Drug Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Bausch Health Recent Developments/Updates
7.5.6 Bausch Health Competitive Strengths & Weaknesses
7.6 Mylan NV
7.6.1 Mylan NV Details
7.6.2 Mylan NV Major Business
7.6.3 Mylan NV High-end Generic Drug Product and Services
7.6.4 Mylan NV High-end Generic Drug Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Mylan NV Recent Developments/Updates
7.6.6 Mylan NV Competitive Strengths & Weaknesses
7.7 Novartis AG
7.7.1 Novartis AG Details
7.7.2 Novartis AG Major Business
7.7.3 Novartis AG High-end Generic Drug Product and Services
7.7.4 Novartis AG High-end Generic Drug Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Novartis AG Recent Developments/Updates
7.7.6 Novartis AG Competitive Strengths & Weaknesses
7.8 Pfizer Inc
7.8.1 Pfizer Inc Details
7.8.2 Pfizer Inc Major Business
7.8.3 Pfizer Inc High-end Generic Drug Product and Services
7.8.4 Pfizer Inc High-end Generic Drug Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Pfizer Inc Recent Developments/Updates
7.8.6 Pfizer Inc Competitive Strengths & Weaknesses
7.9 Fresenius SE & Co
7.9.1 Fresenius SE & Co Details
7.9.2 Fresenius SE & Co Major Business
7.9.3 Fresenius SE & Co High-end Generic Drug Product and Services
7.9.4 Fresenius SE & Co High-end Generic Drug Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Fresenius SE & Co Recent Developments/Updates
7.9.6 Fresenius SE & Co Competitive Strengths & Weaknesses
7.10 Lupin Limited
7.10.1 Lupin Limited Details
7.10.2 Lupin Limited Major Business
7.10.3 Lupin Limited High-end Generic Drug Product and Services
7.10.4 Lupin Limited High-end Generic Drug Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Lupin Limited Recent Developments/Updates
7.10.6 Lupin Limited Competitive Strengths & Weaknesses
7.11 Endo Pharmaceuticals Inc
7.11.1 Endo Pharmaceuticals Inc Details
7.11.2 Endo Pharmaceuticals Inc Major Business
7.11.3 Endo Pharmaceuticals Inc High-end Generic Drug Product and Services
7.11.4 Endo Pharmaceuticals Inc High-end Generic Drug Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Endo Pharmaceuticals Inc Recent Developments/Updates
7.11.6 Endo Pharmaceuticals Inc Competitive Strengths & Weaknesses
7.12 Aurobindo Pharma Limited
7.12.1 Aurobindo Pharma Limited Details
7.12.2 Aurobindo Pharma Limited Major Business
7.12.3 Aurobindo Pharma Limited High-end Generic Drug Product and Services
7.12.4 Aurobindo Pharma Limited High-end Generic Drug Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Aurobindo Pharma Limited Recent Developments/Updates
7.12.6 Aurobindo Pharma Limited Competitive Strengths & Weaknesses
7.13 Warner (India) Pharma Private Limited
7.13.1 Warner (India) Pharma Private Limited Details
7.13.2 Warner (India) Pharma Private Limited Major Business
7.13.3 Warner (India) Pharma Private Limited High-end Generic Drug Product and Services
7.13.4 Warner (India) Pharma Private Limited High-end Generic Drug Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Warner (India) Pharma Private Limited Recent Developments/Updates
7.13.6 Warner (India) Pharma Private Limited Competitive Strengths & Weaknesses
7.14 Shijiazhuang Pharma Group
7.14.1 Shijiazhuang Pharma Group Details
7.14.2 Shijiazhuang Pharma Group Major Business
7.14.3 Shijiazhuang Pharma Group High-end Generic Drug Product and Services
7.14.4 Shijiazhuang Pharma Group High-end Generic Drug Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Shijiazhuang Pharma Group Recent Developments/Updates
7.14.6 Shijiazhuang Pharma Group Competitive Strengths & Weaknesses
7.15 Fosun Pharma
7.15.1 Fosun Pharma Details
7.15.2 Fosun Pharma Major Business
7.15.3 Fosun Pharma High-end Generic Drug Product and Services
7.15.4 Fosun Pharma High-end Generic Drug Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Fosun Pharma Recent Developments/Updates
7.15.6 Fosun Pharma Competitive Strengths & Weaknesses
7.16 Yangtze River Pharmaceutical Group
7.16.1 Yangtze River Pharmaceutical Group Details
7.16.2 Yangtze River Pharmaceutical Group Major Business
7.16.3 Yangtze River Pharmaceutical Group High-end Generic Drug Product and Services
7.16.4 Yangtze River Pharmaceutical Group High-end Generic Drug Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Yangtze River Pharmaceutical Group Recent Developments/Updates
7.16.6 Yangtze River Pharmaceutical Group Competitive Strengths & Weaknesses
7.17 Sichuan KELUN PHARMACEUTICAL Co., Ltd.
7.17.1 Sichuan KELUN PHARMACEUTICAL Co., Ltd. Details
7.17.2 Sichuan KELUN PHARMACEUTICAL Co., Ltd. Major Business
7.17.3 Sichuan KELUN PHARMACEUTICAL Co., Ltd. High-end Generic Drug Product and Services
7.17.4 Sichuan KELUN PHARMACEUTICAL Co., Ltd. High-end Generic Drug Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 Sichuan KELUN PHARMACEUTICAL Co., Ltd. Recent Developments/Updates
7.17.6 Sichuan KELUN PHARMACEUTICAL Co., Ltd. Competitive Strengths & Weaknesses
7.18 Nantong Beite Pharmaceutical Machinery Co.,Ltd
7.18.1 Nantong Beite Pharmaceutical Machinery Co.,Ltd Details
7.18.2 Nantong Beite Pharmaceutical Machinery Co.,Ltd Major Business
7.18.3 Nantong Beite Pharmaceutical Machinery Co.,Ltd High-end Generic Drug Product and Services
7.18.4 Nantong Beite Pharmaceutical Machinery Co.,Ltd High-end Generic Drug Revenue, Gross Margin and Market Share (2018-2023)
7.18.5 Nantong Beite Pharmaceutical Machinery Co.,Ltd Recent Developments/Updates
7.18.6 Nantong Beite Pharmaceutical Machinery Co.,Ltd Competitive Strengths & Weaknesses
7.19 CR Pharmaceutical Group
7.19.1 CR Pharmaceutical Group Details
7.19.2 CR Pharmaceutical Group Major Business
7.19.3 CR Pharmaceutical Group High-end Generic Drug Product and Services
7.19.4 CR Pharmaceutical Group High-end Generic Drug Revenue, Gross Margin and Market Share (2018-2023)
7.19.5 CR Pharmaceutical Group Recent Developments/Updates
7.19.6 CR Pharmaceutical Group Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 High-end Generic Drug Industry Chain
8.2 High-end Generic Drug Upstream Analysis
8.3 High-end Generic Drug Midstream Analysis
8.4 High-end Generic Drug Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World High-end Generic Drug Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World High-end Generic Drug Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World High-end Generic Drug Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World High-end Generic Drug Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World High-end Generic Drug Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World High-end Generic Drug Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World High-end Generic Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World High-end Generic Drug Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World High-end Generic Drug Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key High-end Generic Drug Players in 2022
Table 12. World High-end Generic Drug Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global High-end Generic Drug Company Evaluation Quadrant
Table 14. Head Office of Key High-end Generic Drug Player
Table 15. High-end Generic Drug Market: Company Product Type Footprint
Table 16. High-end Generic Drug Market: Company Product Application Footprint
Table 17. High-end Generic Drug Mergers & Acquisitions Activity
Table 18. United States VS China High-end Generic Drug Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China High-end Generic Drug Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based High-end Generic Drug Companies, Headquarters (States, Country)
Table 21. United States Based Companies High-end Generic Drug Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies High-end Generic Drug Revenue Market Share (2018-2023)
Table 23. China Based High-end Generic Drug Companies, Headquarters (Province, Country)
Table 24. China Based Companies High-end Generic Drug Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies High-end Generic Drug Revenue Market Share (2018-2023)
Table 26. Rest of World Based High-end Generic Drug Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies High-end Generic Drug Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies High-end Generic Drug Revenue Market Share (2018-2023)
Table 29. World High-end Generic Drug Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World High-end Generic Drug Market Size by Type (2018-2023) & (USD Million)
Table 31. World High-end Generic Drug Market Size by Type (2024-2029) & (USD Million)
Table 32. World High-end Generic Drug Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World High-end Generic Drug Market Size by Application (2018-2023) & (USD Million)
Table 34. World High-end Generic Drug Market Size by Application (2024-2029) & (USD Million)
Table 35. Viatris Basic Information, Area Served and Competitors
Table 36. Viatris Major Business
Table 37. Viatris High-end Generic Drug Product and Services
Table 38. Viatris High-end Generic Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Viatris Recent Developments/Updates
Table 40. Viatris Competitive Strengths & Weaknesses
Table 41. Teva Basic Information, Area Served and Competitors
Table 42. Teva Major Business
Table 43. Teva High-end Generic Drug Product and Services
Table 44. Teva High-end Generic Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Teva Recent Developments/Updates
Table 46. Teva Competitive Strengths & Weaknesses
Table 47. Organon Basic Information, Area Served and Competitors
Table 48. Organon Major Business
Table 49. Organon High-end Generic Drug Product and Services
Table 50. Organon High-end Generic Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Organon Recent Developments/Updates
Table 52. Organon Competitive Strengths & Weaknesses
Table 53. Sun Pharma Basic Information, Area Served and Competitors
Table 54. Sun Pharma Major Business
Table 55. Sun Pharma High-end Generic Drug Product and Services
Table 56. Sun Pharma High-end Generic Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Sun Pharma Recent Developments/Updates
Table 58. Sun Pharma Competitive Strengths & Weaknesses
Table 59. Bausch Health Basic Information, Area Served and Competitors
Table 60. Bausch Health Major Business
Table 61. Bausch Health High-end Generic Drug Product and Services
Table 62. Bausch Health High-end Generic Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Bausch Health Recent Developments/Updates
Table 64. Bausch Health Competitive Strengths & Weaknesses
Table 65. Mylan NV Basic Information, Area Served and Competitors
Table 66. Mylan NV Major Business
Table 67. Mylan NV High-end Generic Drug Product and Services
Table 68. Mylan NV High-end Generic Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Mylan NV Recent Developments/Updates
Table 70. Mylan NV Competitive Strengths & Weaknesses
Table 71. Novartis AG Basic Information, Area Served and Competitors
Table 72. Novartis AG Major Business
Table 73. Novartis AG High-end Generic Drug Product and Services
Table 74. Novartis AG High-end Generic Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Novartis AG Recent Developments/Updates
Table 76. Novartis AG Competitive Strengths & Weaknesses
Table 77. Pfizer Inc Basic Information, Area Served and Competitors
Table 78. Pfizer Inc Major Business
Table 79. Pfizer Inc High-end Generic Drug Product and Services
Table 80. Pfizer Inc High-end Generic Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Pfizer Inc Recent Developments/Updates
Table 82. Pfizer Inc Competitive Strengths & Weaknesses
Table 83. Fresenius SE & Co Basic Information, Area Served and Competitors
Table 84. Fresenius SE & Co Major Business
Table 85. Fresenius SE & Co High-end Generic Drug Product and Services
Table 86. Fresenius SE & Co High-end Generic Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Fresenius SE & Co Recent Developments/Updates
Table 88. Fresenius SE & Co Competitive Strengths & Weaknesses
Table 89. Lupin Limited Basic Information, Area Served and Competitors
Table 90. Lupin Limited Major Business
Table 91. Lupin Limited High-end Generic Drug Product and Services
Table 92. Lupin Limited High-end Generic Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Lupin Limited Recent Developments/Updates
Table 94. Lupin Limited Competitive Strengths & Weaknesses
Table 95. Endo Pharmaceuticals Inc Basic Information, Area Served and Competitors
Table 96. Endo Pharmaceuticals Inc Major Business
Table 97. Endo Pharmaceuticals Inc High-end Generic Drug Product and Services
Table 98. Endo Pharmaceuticals Inc High-end Generic Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Endo Pharmaceuticals Inc Recent Developments/Updates
Table 100. Endo Pharmaceuticals Inc Competitive Strengths & Weaknesses
Table 101. Aurobindo Pharma Limited Basic Information, Area Served and Competitors
Table 102. Aurobindo Pharma Limited Major Business
Table 103. Aurobindo Pharma Limited High-end Generic Drug Product and Services
Table 104. Aurobindo Pharma Limited High-end Generic Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Aurobindo Pharma Limited Recent Developments/Updates
Table 106. Aurobindo Pharma Limited Competitive Strengths & Weaknesses
Table 107. Warner (India) Pharma Private Limited Basic Information, Area Served and Competitors
Table 108. Warner (India) Pharma Private Limited Major Business
Table 109. Warner (India) Pharma Private Limited High-end Generic Drug Product and Services
Table 110. Warner (India) Pharma Private Limited High-end Generic Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Warner (India) Pharma Private Limited Recent Developments/Updates
Table 112. Warner (India) Pharma Private Limited Competitive Strengths & Weaknesses
Table 113. Shijiazhuang Pharma Group Basic Information, Area Served and Competitors
Table 114. Shijiazhuang Pharma Group Major Business
Table 115. Shijiazhuang Pharma Group High-end Generic Drug Product and Services
Table 116. Shijiazhuang Pharma Group High-end Generic Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Shijiazhuang Pharma Group Recent Developments/Updates
Table 118. Shijiazhuang Pharma Group Competitive Strengths & Weaknesses
Table 119. Fosun Pharma Basic Information, Area Served and Competitors
Table 120. Fosun Pharma Major Business
Table 121. Fosun Pharma High-end Generic Drug Product and Services
Table 122. Fosun Pharma High-end Generic Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Fosun Pharma Recent Developments/Updates
Table 124. Fosun Pharma Competitive Strengths & Weaknesses
Table 125. Yangtze River Pharmaceutical Group Basic Information, Area Served and Competitors
Table 126. Yangtze River Pharmaceutical Group Major Business
Table 127. Yangtze River Pharmaceutical Group High-end Generic Drug Product and Services
Table 128. Yangtze River Pharmaceutical Group High-end Generic Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. Yangtze River Pharmaceutical Group Recent Developments/Updates
Table 130. Yangtze River Pharmaceutical Group Competitive Strengths & Weaknesses
Table 131. Sichuan KELUN PHARMACEUTICAL Co., Ltd. Basic Information, Area Served and Competitors
Table 132. Sichuan KELUN PHARMACEUTICAL Co., Ltd. Major Business
Table 133. Sichuan KELUN PHARMACEUTICAL Co., Ltd. High-end Generic Drug Product and Services
Table 134. Sichuan KELUN PHARMACEUTICAL Co., Ltd. High-end Generic Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. Sichuan KELUN PHARMACEUTICAL Co., Ltd. Recent Developments/Updates
Table 136. Sichuan KELUN PHARMACEUTICAL Co., Ltd. Competitive Strengths & Weaknesses
Table 137. Nantong Beite Pharmaceutical Machinery Co.,Ltd Basic Information, Area Served and Competitors
Table 138. Nantong Beite Pharmaceutical Machinery Co.,Ltd Major Business
Table 139. Nantong Beite Pharmaceutical Machinery Co.,Ltd High-end Generic Drug Product and Services
Table 140. Nantong Beite Pharmaceutical Machinery Co.,Ltd High-end Generic Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 141. Nantong Beite Pharmaceutical Machinery Co.,Ltd Recent Developments/Updates
Table 142. CR Pharmaceutical Group Basic Information, Area Served and Competitors
Table 143. CR Pharmaceutical Group Major Business
Table 144. CR Pharmaceutical Group High-end Generic Drug Product and Services
Table 145. CR Pharmaceutical Group High-end Generic Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 146. Global Key Players of High-end Generic Drug Upstream (Raw Materials)
Table 147. High-end Generic Drug Typical Customers
List of Figure
Figure 1. High-end Generic Drug Picture
Figure 2. World High-end Generic Drug Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World High-end Generic Drug Total Market Size (2018-2029) & (USD Million)
Figure 4. World High-end Generic Drug Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World High-end Generic Drug Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company High-end Generic Drug Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company High-end Generic Drug Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company High-end Generic Drug Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company High-end Generic Drug Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company High-end Generic Drug Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company High-end Generic Drug Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company High-end Generic Drug Revenue (2018-2029) & (USD Million)
Figure 13. High-end Generic Drug Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World High-end Generic Drug Consumption Value (2018-2029) & (USD Million)
Figure 16. World High-end Generic Drug Consumption Value Market Share by Region (2018-2029)
Figure 17. United States High-end Generic Drug Consumption Value (2018-2029) & (USD Million)
Figure 18. China High-end Generic Drug Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe High-end Generic Drug Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan High-end Generic Drug Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea High-end Generic Drug Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN High-end Generic Drug Consumption Value (2018-2029) & (USD Million)
Figure 23. India High-end Generic Drug Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of High-end Generic Drug by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for High-end Generic Drug Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for High-end Generic Drug Markets in 2022
Figure 27. United States VS China: High-end Generic Drug Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: High-end Generic Drug Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World High-end Generic Drug Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World High-end Generic Drug Market Size Market Share by Type in 2022
Figure 31. Prescription Drugs
Figure 32. Non-prescription Drugs
Figure 33. World High-end Generic Drug Market Size Market Share by Type (2018-2029)
Figure 34. World High-end Generic Drug Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World High-end Generic Drug Market Size Market Share by Application in 2022
Figure 36. Hospital
Figure 37. Pharmacy
Figure 38. Others
Figure 39. High-end Generic Drug Industrial Chain
Figure 40. Methodology
Figure 41. Research Process and Data Source
Table 1. World High-end Generic Drug Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World High-end Generic Drug Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World High-end Generic Drug Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World High-end Generic Drug Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World High-end Generic Drug Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World High-end Generic Drug Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World High-end Generic Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World High-end Generic Drug Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World High-end Generic Drug Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key High-end Generic Drug Players in 2022
Table 12. World High-end Generic Drug Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global High-end Generic Drug Company Evaluation Quadrant
Table 14. Head Office of Key High-end Generic Drug Player
Table 15. High-end Generic Drug Market: Company Product Type Footprint
Table 16. High-end Generic Drug Market: Company Product Application Footprint
Table 17. High-end Generic Drug Mergers & Acquisitions Activity
Table 18. United States VS China High-end Generic Drug Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China High-end Generic Drug Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based High-end Generic Drug Companies, Headquarters (States, Country)
Table 21. United States Based Companies High-end Generic Drug Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies High-end Generic Drug Revenue Market Share (2018-2023)
Table 23. China Based High-end Generic Drug Companies, Headquarters (Province, Country)
Table 24. China Based Companies High-end Generic Drug Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies High-end Generic Drug Revenue Market Share (2018-2023)
Table 26. Rest of World Based High-end Generic Drug Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies High-end Generic Drug Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies High-end Generic Drug Revenue Market Share (2018-2023)
Table 29. World High-end Generic Drug Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World High-end Generic Drug Market Size by Type (2018-2023) & (USD Million)
Table 31. World High-end Generic Drug Market Size by Type (2024-2029) & (USD Million)
Table 32. World High-end Generic Drug Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World High-end Generic Drug Market Size by Application (2018-2023) & (USD Million)
Table 34. World High-end Generic Drug Market Size by Application (2024-2029) & (USD Million)
Table 35. Viatris Basic Information, Area Served and Competitors
Table 36. Viatris Major Business
Table 37. Viatris High-end Generic Drug Product and Services
Table 38. Viatris High-end Generic Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Viatris Recent Developments/Updates
Table 40. Viatris Competitive Strengths & Weaknesses
Table 41. Teva Basic Information, Area Served and Competitors
Table 42. Teva Major Business
Table 43. Teva High-end Generic Drug Product and Services
Table 44. Teva High-end Generic Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Teva Recent Developments/Updates
Table 46. Teva Competitive Strengths & Weaknesses
Table 47. Organon Basic Information, Area Served and Competitors
Table 48. Organon Major Business
Table 49. Organon High-end Generic Drug Product and Services
Table 50. Organon High-end Generic Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Organon Recent Developments/Updates
Table 52. Organon Competitive Strengths & Weaknesses
Table 53. Sun Pharma Basic Information, Area Served and Competitors
Table 54. Sun Pharma Major Business
Table 55. Sun Pharma High-end Generic Drug Product and Services
Table 56. Sun Pharma High-end Generic Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Sun Pharma Recent Developments/Updates
Table 58. Sun Pharma Competitive Strengths & Weaknesses
Table 59. Bausch Health Basic Information, Area Served and Competitors
Table 60. Bausch Health Major Business
Table 61. Bausch Health High-end Generic Drug Product and Services
Table 62. Bausch Health High-end Generic Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Bausch Health Recent Developments/Updates
Table 64. Bausch Health Competitive Strengths & Weaknesses
Table 65. Mylan NV Basic Information, Area Served and Competitors
Table 66. Mylan NV Major Business
Table 67. Mylan NV High-end Generic Drug Product and Services
Table 68. Mylan NV High-end Generic Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Mylan NV Recent Developments/Updates
Table 70. Mylan NV Competitive Strengths & Weaknesses
Table 71. Novartis AG Basic Information, Area Served and Competitors
Table 72. Novartis AG Major Business
Table 73. Novartis AG High-end Generic Drug Product and Services
Table 74. Novartis AG High-end Generic Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Novartis AG Recent Developments/Updates
Table 76. Novartis AG Competitive Strengths & Weaknesses
Table 77. Pfizer Inc Basic Information, Area Served and Competitors
Table 78. Pfizer Inc Major Business
Table 79. Pfizer Inc High-end Generic Drug Product and Services
Table 80. Pfizer Inc High-end Generic Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Pfizer Inc Recent Developments/Updates
Table 82. Pfizer Inc Competitive Strengths & Weaknesses
Table 83. Fresenius SE & Co Basic Information, Area Served and Competitors
Table 84. Fresenius SE & Co Major Business
Table 85. Fresenius SE & Co High-end Generic Drug Product and Services
Table 86. Fresenius SE & Co High-end Generic Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Fresenius SE & Co Recent Developments/Updates
Table 88. Fresenius SE & Co Competitive Strengths & Weaknesses
Table 89. Lupin Limited Basic Information, Area Served and Competitors
Table 90. Lupin Limited Major Business
Table 91. Lupin Limited High-end Generic Drug Product and Services
Table 92. Lupin Limited High-end Generic Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Lupin Limited Recent Developments/Updates
Table 94. Lupin Limited Competitive Strengths & Weaknesses
Table 95. Endo Pharmaceuticals Inc Basic Information, Area Served and Competitors
Table 96. Endo Pharmaceuticals Inc Major Business
Table 97. Endo Pharmaceuticals Inc High-end Generic Drug Product and Services
Table 98. Endo Pharmaceuticals Inc High-end Generic Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Endo Pharmaceuticals Inc Recent Developments/Updates
Table 100. Endo Pharmaceuticals Inc Competitive Strengths & Weaknesses
Table 101. Aurobindo Pharma Limited Basic Information, Area Served and Competitors
Table 102. Aurobindo Pharma Limited Major Business
Table 103. Aurobindo Pharma Limited High-end Generic Drug Product and Services
Table 104. Aurobindo Pharma Limited High-end Generic Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Aurobindo Pharma Limited Recent Developments/Updates
Table 106. Aurobindo Pharma Limited Competitive Strengths & Weaknesses
Table 107. Warner (India) Pharma Private Limited Basic Information, Area Served and Competitors
Table 108. Warner (India) Pharma Private Limited Major Business
Table 109. Warner (India) Pharma Private Limited High-end Generic Drug Product and Services
Table 110. Warner (India) Pharma Private Limited High-end Generic Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Warner (India) Pharma Private Limited Recent Developments/Updates
Table 112. Warner (India) Pharma Private Limited Competitive Strengths & Weaknesses
Table 113. Shijiazhuang Pharma Group Basic Information, Area Served and Competitors
Table 114. Shijiazhuang Pharma Group Major Business
Table 115. Shijiazhuang Pharma Group High-end Generic Drug Product and Services
Table 116. Shijiazhuang Pharma Group High-end Generic Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Shijiazhuang Pharma Group Recent Developments/Updates
Table 118. Shijiazhuang Pharma Group Competitive Strengths & Weaknesses
Table 119. Fosun Pharma Basic Information, Area Served and Competitors
Table 120. Fosun Pharma Major Business
Table 121. Fosun Pharma High-end Generic Drug Product and Services
Table 122. Fosun Pharma High-end Generic Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Fosun Pharma Recent Developments/Updates
Table 124. Fosun Pharma Competitive Strengths & Weaknesses
Table 125. Yangtze River Pharmaceutical Group Basic Information, Area Served and Competitors
Table 126. Yangtze River Pharmaceutical Group Major Business
Table 127. Yangtze River Pharmaceutical Group High-end Generic Drug Product and Services
Table 128. Yangtze River Pharmaceutical Group High-end Generic Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. Yangtze River Pharmaceutical Group Recent Developments/Updates
Table 130. Yangtze River Pharmaceutical Group Competitive Strengths & Weaknesses
Table 131. Sichuan KELUN PHARMACEUTICAL Co., Ltd. Basic Information, Area Served and Competitors
Table 132. Sichuan KELUN PHARMACEUTICAL Co., Ltd. Major Business
Table 133. Sichuan KELUN PHARMACEUTICAL Co., Ltd. High-end Generic Drug Product and Services
Table 134. Sichuan KELUN PHARMACEUTICAL Co., Ltd. High-end Generic Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. Sichuan KELUN PHARMACEUTICAL Co., Ltd. Recent Developments/Updates
Table 136. Sichuan KELUN PHARMACEUTICAL Co., Ltd. Competitive Strengths & Weaknesses
Table 137. Nantong Beite Pharmaceutical Machinery Co.,Ltd Basic Information, Area Served and Competitors
Table 138. Nantong Beite Pharmaceutical Machinery Co.,Ltd Major Business
Table 139. Nantong Beite Pharmaceutical Machinery Co.,Ltd High-end Generic Drug Product and Services
Table 140. Nantong Beite Pharmaceutical Machinery Co.,Ltd High-end Generic Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 141. Nantong Beite Pharmaceutical Machinery Co.,Ltd Recent Developments/Updates
Table 142. CR Pharmaceutical Group Basic Information, Area Served and Competitors
Table 143. CR Pharmaceutical Group Major Business
Table 144. CR Pharmaceutical Group High-end Generic Drug Product and Services
Table 145. CR Pharmaceutical Group High-end Generic Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 146. Global Key Players of High-end Generic Drug Upstream (Raw Materials)
Table 147. High-end Generic Drug Typical Customers
List of Figure
Figure 1. High-end Generic Drug Picture
Figure 2. World High-end Generic Drug Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World High-end Generic Drug Total Market Size (2018-2029) & (USD Million)
Figure 4. World High-end Generic Drug Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World High-end Generic Drug Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company High-end Generic Drug Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company High-end Generic Drug Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company High-end Generic Drug Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company High-end Generic Drug Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company High-end Generic Drug Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company High-end Generic Drug Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company High-end Generic Drug Revenue (2018-2029) & (USD Million)
Figure 13. High-end Generic Drug Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World High-end Generic Drug Consumption Value (2018-2029) & (USD Million)
Figure 16. World High-end Generic Drug Consumption Value Market Share by Region (2018-2029)
Figure 17. United States High-end Generic Drug Consumption Value (2018-2029) & (USD Million)
Figure 18. China High-end Generic Drug Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe High-end Generic Drug Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan High-end Generic Drug Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea High-end Generic Drug Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN High-end Generic Drug Consumption Value (2018-2029) & (USD Million)
Figure 23. India High-end Generic Drug Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of High-end Generic Drug by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for High-end Generic Drug Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for High-end Generic Drug Markets in 2022
Figure 27. United States VS China: High-end Generic Drug Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: High-end Generic Drug Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World High-end Generic Drug Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World High-end Generic Drug Market Size Market Share by Type in 2022
Figure 31. Prescription Drugs
Figure 32. Non-prescription Drugs
Figure 33. World High-end Generic Drug Market Size Market Share by Type (2018-2029)
Figure 34. World High-end Generic Drug Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World High-end Generic Drug Market Size Market Share by Application in 2022
Figure 36. Hospital
Figure 37. Pharmacy
Figure 38. Others
Figure 39. High-end Generic Drug Industrial Chain
Figure 40. Methodology
Figure 41. Research Process and Data Source
